Morgan Stanley Lowers Molina Healthcare (MOH) Price Target to $91.00

Molina Healthcare (NYSE:MOH) had its target price reduced by Morgan Stanley from $94.00 to $91.00 in a report released on Wednesday, February 14th. They currently have an overweight rating on the stock.

A number of other equities analysts also recently commented on MOH. ValuEngine upgraded shares of Molina Healthcare from a hold rating to a buy rating in a research report on Thursday, November 9th. Jefferies Group reissued a hold rating and issued a $80.00 price objective on shares of Molina Healthcare in a research note on Wednesday, February 14th. Zacks Investment Research lowered shares of Molina Healthcare from a strong-buy rating to a hold rating in a report on Friday, February 9th. Raymond James Financial reiterated a hold rating on shares of Molina Healthcare in a report on Friday, December 8th. Finally, Goldman Sachs Group initiated coverage on shares of Molina Healthcare in a report on Wednesday, January 3rd. They set a neutral rating and a $83.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. Molina Healthcare currently has a consensus rating of Hold and a consensus target price of $73.73.

Molina Healthcare (NYSE MOH) traded up $1.38 during midday trading on Wednesday, reaching $72.94. 1,230,000 shares of the company’s stock traded hands, compared to its average volume of 1,420,000. The firm has a market cap of $4,160.00, a PE ratio of -9.03, a PEG ratio of 1.29 and a beta of 1.10. The company has a quick ratio of 1.29, a current ratio of 1.35 and a debt-to-equity ratio of 1.13. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $93.98.

In related news, COO Terry Bayer sold 2,804 shares of the business’s stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $91.63, for a total value of $256,930.52. Following the completion of the sale, the chief operating officer now directly owns 70,092 shares in the company, valued at approximately $6,422,529.96. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director John C. Molina sold 5,385 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $92.88, for a total value of $500,158.80. Following the completion of the sale, the director now owns 414,151 shares of the company’s stock, valued at $38,466,344.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 751,453 shares of company stock worth $59,343,324. Company insiders own 6.20% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Ameritas Investment Partners Inc. lifted its stake in Molina Healthcare by 2.2% in the second quarter. Ameritas Investment Partners Inc. now owns 16,659 shares of the company’s stock valued at $1,152,000 after buying an additional 364 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Molina Healthcare by 40.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after acquiring an additional 690 shares during the period. Moody Aldrich Partners LLC increased its stake in Molina Healthcare by 14.4% during the 3rd quarter. Moody Aldrich Partners LLC now owns 5,973 shares of the company’s stock worth $411,000 after acquiring an additional 753 shares during the period. Comerica Bank increased its stake in Molina Healthcare by 2.8% during the 3rd quarter. Comerica Bank now owns 34,098 shares of the company’s stock worth $2,273,000 after acquiring an additional 939 shares during the period. Finally, Meadow Creek Investment Management LLC increased its stake in Molina Healthcare by 22.9% during the 4th quarter. Meadow Creek Investment Management LLC now owns 5,404 shares of the company’s stock worth $414,000 after acquiring an additional 1,008 shares during the period. Institutional investors own 96.22% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Morgan Stanley Lowers Molina Healthcare (MOH) Price Target to $91.00” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://stocknewstimes.com/2018/02/25/molina-healthcare-moh-price-target-cut-to-91-00-by-analysts-at-morgan-stanley.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply